close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Health & Science Gilead Sciences Inc Technology
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Alzheimer's disease Daily Open Asia Markets
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Alzheimer's disease Asia Markets Daily Open
From CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
Tags Eli Lilly and Co US: News Business News
From CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags Exchange/traded funds Eaton Corporation PLC ETF Edge
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Novo Nordisk A/S Oracle Corp Healthy Returns
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags Investing Business THE JM SMUCKDRN
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags US: News Business News Asia: Top News and Analysis
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags US: News Business News Pharmaceuticals
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Companies Business Biotech and Pharmaceuticals
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Europe Markets Breaking News: Markets Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Labor economy Health care industry Social issues
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Health care industry Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Business News Mad Money stocks
From CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
Tags Health care industry Health & Science Eli Lilly and Co
From CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
Tickers RH
Tags Oracle Corp NVIDIA Corp Apple Inc
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Johnson & Johnson Eli Lilly and Co Moderna Inc
From CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
Tags Pharmaceuticals Alphabet Inc Internet
From CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
Tags Eli Lilly and Co Technology Alphabet Inc
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Employee benefits Business News Health insurance
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Business News Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Stock markets U/S/ Markets Eli Lilly and Co
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Goldman Sachs Group Inc Health & Science Technology
From CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Tags US: News Pharmaceuticals Biotechnology
From CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
Tags Markets Investment Strategy Business News
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Pro: Investing trends Health & Science Eli Lilly and Co
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Novo Nordisk A/S Uber Technologies Inc Healthy Returns
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags US: News Carmot Therapeutics Inc Business News
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Science Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Eli Lilly and Co US: News Business News
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today